Corporate ActionOct 27, 2026, 01:01 PM
RegenLab USA Inc. Files S-1/A for IPO, Announces 3.2-for-1 Stock Split
AI Summary
RegenLab USA, Inc. has filed an S-1/A amendment detailing its upcoming initial public offering (IPO). The company plans a 3.2-for-1 forward stock split prior to the offering of 2,500,000 shares, with an anticipated price range of $6.00 to $8.00 per share. RegenLab has applied for listing on the Nasdaq under the symbol 'RGNA'. The filing also notes that the principal stockholder will retain significant control post-offering, and outlines the underwriters' option for additional shares.
Key Highlights
- RegenLab USA, Inc. plans a 3.2-for-1 forward stock split of its issued and outstanding common stock.
- The company is offering 2,500,000 shares of common stock in its initial public offering.
- The anticipated initial public offering price is between $6.00 and $8.00 per share.
- RegenLab has applied to list its common stock on the Nasdaq Stock Market under the symbol 'RGNA'.
- Mr. Antonino Turzi will control approximately 87.66% of the voting power post-offering.
- The company has granted underwriters an option to purchase up to 375,000 additional shares for over-allotments.
Price Impact